Traders Buy Shares of Express Scripts (ESRX) on Weakness Following Analyst Downgrade

Traders purchased shares of Express Scripts (NASDAQ:ESRX) on weakness during trading hours on Friday after BidaskClub downgraded the stock from a buy rating to a hold rating. $94.69 million flowed into the stock on the tick-up and $62.38 million flowed out of the stock on the tick-down, for a money net flow of $32.31 million into the stock. Of all equities tracked, Express Scripts had the 2nd highest net in-flow for the day. Express Scripts traded down ($1.98) for the day and closed at $70.22

Other equities research analysts have also recently issued research reports about the stock. Maxim Group lifted their price target on shares of Express Scripts from $87.00 to $101.00 in a report on Wednesday, February 28th. Zacks Investment Research upgraded shares of Express Scripts from a “hold” rating to a “buy” rating and set a $82.00 price objective for the company in a research note on Wednesday, February 14th. SunTrust Banks reiterated a “buy” rating and issued a $95.00 price objective on shares of Express Scripts in a research note on Friday, January 12th. Robert W. Baird reiterated a “buy” rating and issued a $92.00 price objective (up from $81.00) on shares of Express Scripts in a research note on Tuesday, January 9th. Finally, Jefferies Group set a $91.00 price objective on shares of Express Scripts and gave the company a “buy” rating in a research note on Wednesday, February 28th. Four investment analysts have rated the stock with a sell rating, thirteen have issued a hold rating and five have given a buy rating to the company’s stock. Express Scripts currently has a consensus rating of “Hold” and a consensus price target of $82.50.

In other news, VP Everett Neville sold 4,895 shares of the business’s stock in a transaction on Thursday, March 1st. The shares were sold at an average price of $75.26, for a total transaction of $368,397.70. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Christine Houston sold 19,889 shares of the business’s stock in a transaction on Thursday, March 15th. The shares were sold at an average price of $76.69, for a total transaction of $1,525,287.41. The disclosure for this sale can be found here. 0.79% of the stock is owned by insiders.

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. SeaCrest Wealth Management LLC purchased a new position in shares of Express Scripts during the 4th quarter valued at $105,000. Aevitas Wealth Management Inc. purchased a new position in shares of Express Scripts during the 4th quarter valued at $128,000. Financial Gravity Companies Inc. purchased a new position in shares of Express Scripts during the 4th quarter valued at $142,000. Virtue Capital Management LLC purchased a new position in shares of Express Scripts during the 4th quarter valued at $176,000. Finally, Harvest Fund Management Co. Ltd purchased a new position in shares of Express Scripts during the 4th quarter valued at $183,000. Hedge funds and other institutional investors own 89.28% of the company’s stock.

The company has a current ratio of 0.69, a quick ratio of 0.55 and a debt-to-equity ratio of 0.81. The firm has a market capitalization of $40,542.54, a PE ratio of 9.55, a price-to-earnings-growth ratio of 0.91 and a beta of 0.98.

Express Scripts (NASDAQ:ESRX) last posted its quarterly earnings data on Wednesday, May 2nd. The company reported $1.77 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.76 by $0.01. Express Scripts had a net margin of 4.59% and a return on equity of 25.41%. The company had revenue of $24.77 billion during the quarter, compared to the consensus estimate of $24.80 billion. During the same period in the previous year, the firm posted $1.33 EPS. The firm’s revenue was up .5% compared to the same quarter last year. equities analysts predict that Express Scripts will post 9.11 EPS for the current year.

About Express Scripts

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Western Gas Equity  Getting Somewhat Positive Media Coverage, Report Shows
Western Gas Equity Getting Somewhat Positive Media Coverage, Report Shows
Aetna  Given Consensus Recommendation of “Buy” by Brokerages
Aetna Given Consensus Recommendation of “Buy” by Brokerages
Deutsche Bank  Given Average Recommendation of “Hold” by Brokerages
Deutsche Bank Given Average Recommendation of “Hold” by Brokerages
Xencor  Given Consensus Recommendation of “Buy” by Brokerages
Xencor Given Consensus Recommendation of “Buy” by Brokerages
Financial Comparison: Presidio  & Synnex
Financial Comparison: Presidio & Synnex
Head to Head Review: Full House Resorts  & Penn National Gaming
Head to Head Review: Full House Resorts & Penn National Gaming


© 2006-2018 Ticker Report. Google+.